標(biāo)題: Titlebook: Engineering in Translational Medicine; Weibo Cai Book 2014 Springer-Verlag London 2014 Engineering of Clinical Imaging Systems.Nanoenginee [打印本頁] 作者: 空隙 時間: 2025-3-21 17:57
書目名稱Engineering in Translational Medicine影響因子(影響力)
書目名稱Engineering in Translational Medicine影響因子(影響力)學(xué)科排名
書目名稱Engineering in Translational Medicine網(wǎng)絡(luò)公開度
書目名稱Engineering in Translational Medicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Engineering in Translational Medicine被引頻次
書目名稱Engineering in Translational Medicine被引頻次學(xué)科排名
書目名稱Engineering in Translational Medicine年度引用
書目名稱Engineering in Translational Medicine年度引用學(xué)科排名
書目名稱Engineering in Translational Medicine讀者反饋
書目名稱Engineering in Translational Medicine讀者反饋學(xué)科排名
作者: 綁架 時間: 2025-3-21 21:10
Stem Cells: The Holy Grail of Regenerative Medicineach of “Biological Solutions to Biological Diseases.” Stem cells that reside at the apex of cellular hierarchy are now considered as “Therapeutic wonders” due to their multilineage differentiation and self-renewal properties. These cells depending upon their differentiation potency and site of origi作者: Cocker 時間: 2025-3-22 01:31
Engineering T Cells to Target Tumor Cellster to support tumor growth. The microenvironment of an established tumor is usually immune suppressive, protecting tumor cells from recognition and elimination by effector cells. Genetic engineering can be used to modify T cells ex vivo to improve their functionality in favor of tumor killing. Adop作者: 連系 時間: 2025-3-22 07:41 作者: Carcinoma 時間: 2025-3-22 12:02 作者: Ossification 時間: 2025-3-22 15:51
Structure, Function, and Development of Blood Vessels: Lessons for Tissue Engineeringes early death of embryos, and also dysfunction of endothelial cells (ECs) contributes to many diseases, including stroke, thrombosis, and atherosclerosis. Furthermore, there is a considerable clinical need for alternatives to the autologous vein and artery tissues used for vascular reconstructive s作者: Ossification 時間: 2025-3-22 17:30
Engineering Gene-Activated Matrices for the Repair of Articular Cartilage Defectlage can easily lead to its more serious degeneration, which is one of the leading causes of disability in the elderly. Growth factors have been shown to promote cartilage repair. However, the structure of cartilage tissue has been shown to hinder the direct addition of protein growth factors into t作者: AVID 時間: 2025-3-22 21:55
Engineering Luciferases for Assays and Imagingse proteins, however, have not evolved for the purpose of biomedical research, and it is not surprising that the utility and robustness of these assays can be improved by protein engineering of the luciferase. In this chapter, we provide an overview of luciferases, protein engineering, and how prote作者: Sleep-Paralysis 時間: 2025-3-23 01:33 作者: 懲罰 時間: 2025-3-23 08:16
Engineering Aspects of Bioluminescence Resonance Energy Transfer Systemsuminescence resonance energy transfer (BRET)-based sensors are rapidly expanding and showing great utilities in the study of protein–protein interactions (PPIs), protein dimerization, signal transduction, etc. Since its inception in the late nineties, BRET-related research has gained significant mom作者: 有惡臭 時間: 2025-3-23 11:43
Antibody Engineering in Translational Medicineases. Antibody engineering technologies aim at the development of new generations of antibody-based drugs with more favorable properties, including higher potency or improved safety profiles. This chapter provides an overview over current strategies to tailor Abs for medical applications. While some作者: ARC 時間: 2025-3-23 14:53 作者: 提名的名單 時間: 2025-3-23 20:26 作者: exceed 時間: 2025-3-23 23:24
Engineering Multivalent and Multispecific Protein TherapeuticsTheir mechanisms of action have served as inspiration for the development of next-generation protein therapeutics with improved efficacy and safety profiles. Protein therapeutics leverage the inherent affinity and specificity of protein–protein interactions, offering an effective approach for target作者: IDEAS 時間: 2025-3-24 02:46 作者: 外面 時間: 2025-3-24 07:23 作者: Indent 時間: 2025-3-24 11:26
Engineering DNA Vaccines for Cancer Therapyand/or cellular immunity against tumor cells expressing the encoded antigen. Dozens of DNA vaccines have entered clinical trials for a variety of malignancies, where they have demonstrated efficacy in eliciting immune responses and potential clinical responses. This is further demonstrated by the ap作者: 助記 時間: 2025-3-24 17:10
https://doi.org/10.1007/978-1-4471-4372-7Engineering of Clinical Imaging Systems; Nanoengineering; Protein Engineering; Stem Cell Engineering; Ti作者: ALB 時間: 2025-3-24 19:34 作者: 新娘 時間: 2025-3-25 00:22 作者: 談判 時間: 2025-3-25 06:35
https://doi.org/10.1007/978-1-4615-8726-2ter to support tumor growth. The microenvironment of an established tumor is usually immune suppressive, protecting tumor cells from recognition and elimination by effector cells. Genetic engineering can be used to modify T cells ex vivo to improve their functionality in favor of tumor killing. Adop作者: 數(shù)量 時間: 2025-3-25 09:57 作者: pantomime 時間: 2025-3-25 14:06 作者: 減至最低 時間: 2025-3-25 18:50
https://doi.org/10.1007/978-3-030-62621-1es early death of embryos, and also dysfunction of endothelial cells (ECs) contributes to many diseases, including stroke, thrombosis, and atherosclerosis. Furthermore, there is a considerable clinical need for alternatives to the autologous vein and artery tissues used for vascular reconstructive s作者: AROMA 時間: 2025-3-25 23:07 作者: GORGE 時間: 2025-3-26 00:36
https://doi.org/10.1007/978-1-349-04920-2se proteins, however, have not evolved for the purpose of biomedical research, and it is not surprising that the utility and robustness of these assays can be improved by protein engineering of the luciferase. In this chapter, we provide an overview of luciferases, protein engineering, and how prote作者: 搬運(yùn)工 時間: 2025-3-26 07:45 作者: HERTZ 時間: 2025-3-26 11:00
The Gelfand Mathematical Seminars, 1993–1995uminescence resonance energy transfer (BRET)-based sensors are rapidly expanding and showing great utilities in the study of protein–protein interactions (PPIs), protein dimerization, signal transduction, etc. Since its inception in the late nineties, BRET-related research has gained significant mom作者: 宣稱 時間: 2025-3-26 13:45
https://doi.org/10.1007/978-1-4613-2393-8ases. Antibody engineering technologies aim at the development of new generations of antibody-based drugs with more favorable properties, including higher potency or improved safety profiles. This chapter provides an overview over current strategies to tailor Abs for medical applications. While some作者: 來自于 時間: 2025-3-26 18:56 作者: outer-ear 時間: 2025-3-26 23:21 作者: 帶來的感覺 時間: 2025-3-27 02:43 作者: 神經(jīng) 時間: 2025-3-27 07:17
The Gendered Transaction of Whitenessligands by exponential enrichment (SELEX) technology. Aptamers have high specificity and affinity toward target molecules and exhibit desired thermal stability. Additionally, the oligonucleotide nature makes aptamers easy to be chemically modified or incorporated with other DNA/RNA molecules. Owing 作者: GIBE 時間: 2025-3-27 12:58
The Gendering of Global Financepread applications in medicine. Because of their high specificity of targeting, aptamers offer an innovative highly promising option as delivery agents for nanoparticles, siRNA bioconjugates, chemotherapeutic cargos, and molecular imaging probes. Indeed, aptamers are short, single-stranded oligonucl作者: 刀鋒 時間: 2025-3-27 14:06 作者: ABYSS 時間: 2025-3-27 19:39 作者: 一再遛 時間: 2025-3-28 00:36
Engineering Luciferases for Assays and Imagingse proteins, however, have not evolved for the purpose of biomedical research, and it is not surprising that the utility and robustness of these assays can be improved by protein engineering of the luciferase. In this chapter, we provide an overview of luciferases, protein engineering, and how protein engineering is applied to luciferases.作者: 要控制 時間: 2025-3-28 04:28
978-1-4471-6995-6Springer-Verlag London 2014作者: 橫截,橫斷 時間: 2025-3-28 10:03
Weibo CaiCovers a broad array of topics include cell engineering, nanoengineering, antibody/protein engineering, tissue engineering, and many others.Summarizes the state-of-the-art in the specific research are作者: Institution 時間: 2025-3-28 14:30 作者: 漂白 時間: 2025-3-28 18:28 作者: 慌張 時間: 2025-3-28 21:00
Engineering T Cells to Target Tumor Cells conditional elimination if they induce an unintended immune response or transform to a malignant phenotype. In this chapter, we describe the current status of adoptive therapy for cancer with genetically engineered T cells.作者: 花費(fèi) 時間: 2025-3-29 02:50
Engineering Biomaterials for Anchorage-Dependent and Non-anchorage-Dependent Therapeutic Cell Deliveon-anchorage-dependent cells (non-ADCs) such as chondrocytes and hepatocytes do not and often exhibit a rounded morphology in native environment. Here, the different cell delivery structures and their development in delivering both ADCs and non-ADCs are discussed.作者: 臆斷 時間: 2025-3-29 06:33 作者: Terrace 時間: 2025-3-29 08:25
Alternative Protein Scaffolds for Molecular Imaging and Therapye, production, and/or conjugation. Validated scaffolds include the fibronectin domain, knottin, designed ankyrin repeat protein, anticalin, and affibody among others. These scaffolds have demonstrated efficacy in preclinical animal models and, in some cases, clinical trials in therapy or imaging. Th作者: interpose 時間: 2025-3-29 12:21
Engineering Multivalent and Multispecific Protein Therapeuticsthrough avidity effects, and selectivity for a diseased versus normal state. These aspects lead to greater therapeutic control over an intended biological response, with the potential for reduced side effects. In this chapter, we describe the basic biophysical principles underlying multivalency and 作者: DAUNT 時間: 2025-3-29 17:35
Engineering Aptamers for Biomedical Applications: Part Iment of aptamer-based biosensors and have pushed them closer to clinical applications. In this chapter, we will detail the recent development in engineering aptamers and highlight the work for sensor applications by using engineered aptamers.作者: Liability 時間: 2025-3-29 22:28
Engineering Aptamers for Biomedical Applications: Part IIased therapeutics. As such, aptamers couple the advantages of the specific binding of monoclonal antibodies to the chemical nature of nucleic acids. Here, we will focus on the development of multifunctional aptamer-based bioconjugates for targeted delivery of therapeutics and imaging agents to disea作者: intricacy 時間: 2025-3-30 00:49
Engineering DNA Vaccines for Cancer Therapyss engineering efforts to enhance the immune and anti-tumor efficacy of DNA vaccines, focusing on specific changes that can be made to the DNA backbone to enhance the expression, processing, and presentation of the encoded antigen, as well as improving the inherent immunogenicity of the vaccine itse作者: ADOPT 時間: 2025-3-30 04:30 作者: Colonoscopy 時間: 2025-3-30 11:34 作者: 維持 時間: 2025-3-30 14:16
https://doi.org/10.1007/978-1-4615-8726-2 conditional elimination if they induce an unintended immune response or transform to a malignant phenotype. In this chapter, we describe the current status of adoptive therapy for cancer with genetically engineered T cells.作者: 因無茶而冷淡 時間: 2025-3-30 16:37 作者: Glucocorticoids 時間: 2025-3-31 00:32 作者: 跟隨 時間: 2025-3-31 02:28 作者: hemoglobin 時間: 2025-3-31 07:08 作者: bronchiole 時間: 2025-3-31 10:43 作者: countenance 時間: 2025-3-31 16:26
The Gendering of Global Financeased therapeutics. As such, aptamers couple the advantages of the specific binding of monoclonal antibodies to the chemical nature of nucleic acids. Here, we will focus on the development of multifunctional aptamer-based bioconjugates for targeted delivery of therapeutics and imaging agents to disea作者: antidote 時間: 2025-3-31 20:59 作者: Vulvodynia 時間: 2025-3-31 23:43
